Prognostic significance of stress hyperglycemia ratio in coronary microvascular dysfunction among chronic coronary syndrome patients
Frontiers in Cardiovascular Medicine · 04.06.2026 · 13
DOI: 10.3389/fcvm.2026.1740092 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 04.06.2026. Verfasst von Jiasuer Alifu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China. Die Arbeit nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Aims
Coronary microvascular dysfunction (CMD) is a crucial prognostic indicator in chronic coronary syndrome (CCS) patients. The stress hyperglycemia ratio (SHR), a novel biomarker of acute hyperglycemia, has demonstrated predictive value for adverse outcomes in various diseases. However, its association with CMD remains unclear. This study aims to evaluate the prognostic role of SHR in predicting CMD outcomes in CCS patients.
Methods
CCS patients who underwent coronary angiography (CAG) were included. Microvascular function was assessed using coronary angiography-derived index of microcirculatory resistance (caIMR), with CMD defined as caIMR > 25U. Patients were divided into three groups based on SHR values: T1 (SHR < 0.73), T2 (SHR 0.73–0.80), and T3 (SHR≥0.80). The primary endpoint was major adverse cardiac events (MACE).
Results
379 CCS patients were included, among which 196 were identified with CMD. The CMD group exhibited higher SHR levels. During a mean follow-up of 32.9 months, 53 MACE events occurred in CMD patients, with a higher incidence in the T3 group compared to the T1/T2 groups (37.681% vs. 16.667% vs. 26.230%, P = 0.023). SHR was identified as an independent predictor of CMD (OR 7.379, 95% CI: 1.305–41.725, P = 0.024). The T3 group demonstrated a 2.325-fold increased risk of MACE (HR 2.325, 95% CI: 1.228–5.033, P = 0.011), with a non-linear relationship observed between SHR and MACE (P for non-linear < 0.001).
Conclusions
Elevated SHR is associated with adverse outcomes and predicts MACE in CMD patients with CCS. These results highlight the potential of SHR as a valuable tool for early risk stratification and prevention in CMD management. Trial Registration ClinicalTrials.gov, NCT06698432 (Registration Date: November 19, 2024)
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
- Department of Cardiology, Shanghai Tenth People's Hospital Chongming Branch, Shanghai, China.
Zitieren
APA
Alifu, J., Mamuti, H., Luo, Y., Wang, C., Zhang, W., Qi, P., Mohammed, A. Q., Liu, L., Yin, G., Lv, X., Shi, T., Abdu, F. A., & Che, W. (2026). Prognostic significance of stress hyperglycemia ratio in coronary microvascular dysfunction among chronic coronary syndrome patients. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1740092
Vancouver
Alifu J, Mamuti H, Luo Y, Wang C, Zhang W, Qi P, et al. Prognostic significance of stress hyperglycemia ratio in coronary microvascular dysfunction among chronic coronary syndrome patients. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1740092
BibTeX
@article{Alifu2026,
author = {Alifu, Jiasuer and Mamuti, Hailipai and Luo, Yongqiang and Wang, Chunyue and Zhang, Wen and Qi, Penglong and Mohammed, Abdul-Quddus and Liu, Lu and Yin, Guoqing and Lv, Xian and Shi, Tingting and Abdu, Fuad A and Che, Wenliang},
title = {Prognostic significance of stress hyperglycemia ratio in coronary microvascular dysfunction among chronic coronary syndrome patients},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1740092}
}
EUVIMED